Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 65, Issue 3-4
December 2020
Chemotherapy Cover Image for Volume 65, Issue 3-4
All Issues
ISSN 0009-3157
EISSN 1421-9794

Journal Name Change

Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.

Chemotherapy 2020, Vol. 65, No. 3-4

Antimicrobial Section / Original Paper

A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis
Subject Area: Further Areas , Oncology , Pharmacology
Ryota Tanaka; Takashi Fujioka; Yosuke Suzuki; Motoshi Iwao; Hiroki Itoh
Chemotherapy (2020) 65 (3-4): 59–64. https://doi.org/10.1159/000509970
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Anticancer Section / Review

Modern Radiotherapy and Risk of Cardiotoxicity
Subject Area: Further Areas , Oncology , Pharmacology
Efstratios Koutroumpakis; Nicolas L. Palaskas; Steven H. Lin; Jun-ichi Abe; Zhongxing Liao; Jose Banchs; Anita Deswal; Syed Wamique Yusuf
Chemotherapy (2020) 65 (3-4): 65–76. https://doi.org/10.1159/000510573
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment
Subject Area: Further Areas , Oncology , Pharmacology
Francesco Plotti; Corrado Terranova; Daniela Luvero; Martina Bartolone; Giuseppe Messina; Laura Feole; Stefano Cianci; Giuseppe Scaletta; Claudia Marchetti; Violante Di Donato; Anna Fagotti; Giovanni Scambia; Pierluigi Benedetti Panici; Roberto Angioli
Chemotherapy (2020) 65 (3-4): 77–84. https://doi.org/10.1159/000510839
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Anticancer Section / Original Paper

HDAC3 Silencing Enhances Acute B Lymphoblastic Leukaemia Cells Sensitivity to MG-132 by Inhibiting the JAK/Signal Transducer and Activator of Transcription 3 Signaling Pathway
Subject Area: Further Areas , Oncology , Pharmacology
Yongling Guo; Xinyao Li; Zhengchang He; Dan Ma; Zhaoyuan Zhang; Weili Wang; Jie Xiong; Xinyi Kuang; Jishi Wang
Chemotherapy (2020) 65 (3-4): 85–100. https://doi.org/10.1159/000500713
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Predictors of Response and Survival Outcomes of Triple Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
Subject Area: Further Areas , Oncology , Pharmacology
Meizhen Zhu; Yang Yu; Xiying Shao; Liang Zhu; Linbo Wang
Chemotherapy (2020) 65 (3-4): 101–109. https://doi.org/10.1159/000509638
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Anticancer Section / Letter to the Editor

White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy
Subject Area: Further Areas , Oncology , Pharmacology
Tatiana Marras; Michael Dettori; Giovanni Caocci; Giorgio La Nasa; Giovanni Sotgiu; Laura Saderi; Claudio Fozza
Chemotherapy (2020) 65 (3-4): 110–114. https://doi.org/10.1159/000509816
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Carnitine levels decrease during oxaliplatin infusion; a pilot study
Aerobic exercise alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis
Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
  • Online ISSN 1421-9794
  • Print ISSN 0009-3157
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal